Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Charissa Y, Chang"'
Publikováno v:
Gastroenterology. 162:937-951
Publikováno v:
International Journal of Hepatology, Vol 2013 (2013)
Hepatocellular adenoma (HCA) is a benign neoplasm arising from hepatocytes. There is evidence that the inflammatory subtype may be associated with obesity and alcohol use and that men with metabolic syndrome may be at risk for malignant transformatio
Externí odkaz:
https://doaj.org/article/757bd5cec1344ab9b5d0e982add95ae7
Autor:
Nelson Cheinquer, Natarajan Ravendhran, Didier Samuel, Charissa Y. Chang, Eric Lawitz, Luisa M. Stamm, Christophe Hézode, K. Rajender Reddy, Steven L. Flamm, Brian B. Borg, James Spellman, Gulan Zhang, Michael Charlton, Scott Moon, Mitchell L. Shiffman, Charles Landis, Anuj Gaggar, Angel Alsina
Publikováno v:
Gastroenterology. 156:S-1219
Autor:
Ana C, Tuyama, Charissa Y, Chang
Publikováno v:
Journal of diabetes. 4(3)
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world. It is closely associated with metabolic syndrome. The alarming epidemics of diabetes and obesity have fueled an increasing prevalence of NAFLD, p
Autor:
Stephen H. Caldwell, C.A. Davis, Jan A. Redick, Charissa Y. Chang, Al Osaimi Ka, Curtis K. Argo
Publikováno v:
The American journal of gastroenterology. 101(7)
Enlarged Hepatocytes in NAFLD Examined with Osmium Fixation: Does Microsteatosis Underlie Cellular Ballooning in NASH?
Publikováno v:
Journal of clinical gastroenterology. 40
Lipid peroxidation and secondary cellular injury are the dominant mechanism in the transition from relatively stable hepatic steatosis to potentially progressive steatohepatitis in nonalcoholic fatty liver disease (NAFLD). Oxidation of excessive fatt
Autor:
Jan A. Redick, Stephen H. Caldwell, Lisa Krugner-Higby, Tri H. Le, Abdullah M. S. Al-Osaimi, Elizabeth E. Hespenheide, Charissa Y. Chang, Robert K. Nakamoto, Christie Davis, Julia C. Iezzoni, Theresa C. Peterson, Anita Impaglizzo Hylton
Publikováno v:
NASH and Nutritional Therapy ISBN: 9784431213888
Nonalcoholic fatty liver (NAFL) or nonalcoholic fatty liver disease (NAFLD) as it is often called, is increasingly recognized as a common and potentially severe condition often associated with obesity, type 2 diabetes, and hyperlipidemia. The spectru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e3e58dc9f6a3d20d7261302ad6b2d5a
https://doi.org/10.1007/4-431-27172-4_1
https://doi.org/10.1007/4-431-27172-4_1
Publikováno v:
Clinics in liver disease. 8(3)
Nonalcoholic fatty liver (NAFL) is associated with fundamental issues of fat metabolism and insulin resistance. These abnormalities have been linked to impairment of ATP homeostasis, and a growing body of literature has reported mitochondrial abnorma
Autor:
Charissa Y. Chang, Jan A. Redick, Theresa C. Peterson, Stephen H. Caldwell, Lisa Krugner-Higby, C.A. Davis, A Ms Al-Osaimi, Elizabeth E Hespenheide
Publikováno v:
Alcoholism: Clinical & Experimental Research. 28:64A